2 Result: Psychedelic
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
April 24th, 2026
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders Silver Spring, MD / CRWE PRESS RELEASE / April 24, 2026 - President Trump on April 18. Read more
Breaking: FDA's Psychedelic Drug Trials Draft Guidance Revealed
June 24th, 2023
The U.S. Food and Drug Administration (FDA) has released its first draft guidance on conducting clinical trials with psychedelic drugs for potential medical treatment. Published on June 23, 2023, the guidance aims to provide researchers with importan. Read more
Load More Content
Member Login